Karen McLoughlin - 14 Jul 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Jul 2021
Net transactions value
$0
Form type
4
Filing time
16 Jul 2021, 16:01:16 UTC
Previous filing
14 Jul 2021
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +3,489 $0.000000 3,489 14 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +7,959 $0.000000 7,959 14 Jul 2021 Common Stock 7,959 $34.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vests in full on July 14, 2022, subject to continued service as a director.
F2 Options that vest in three equal installments on each anniversary of July 14, 2021, subject to continued service as a director.